Wellcare | Contract Recertification and Prescription Drug Plan Updates
Important! 2025 Contract Re-certification and Prescription Drug Plan Compensation Updates
We are pleased to announce that 2025 Contract Re-certification will be available in Centene Workbench for your attestation on Sept. 3, 2024! Annually, brokers are required to complete certification requirements to market and sell Medicare Advantage products. All annual certification requirements must be complete by Oct. 1, 2024, to be able to market and sell Wellcare products, avoid suspension, and receive Medicare Advantage compensation.
New in Contract Year 2025
Contract Re-certification will be released independent of Annual Certification Training (ACT) for Contract Year 2025.
By Oct. 1, 2024, you must:
- Execute the 2025 contract through the 2025 Re-certification Workflow in Centene Workbench (in place of the usual Summary of Changes).
- Complete 2025 ACT and AHIP or NABIP Medicare Certification training on or before Oct. 1, 2024, as part of the certification requirements to market and sell 2025 Wellcare MA Part D products.
Note: you will still be prompted to confirm your information on file is current and/or make changes, where needed, in Centene Workbench.
Please be on the lookout for additional communications regarding re-certification.
Prescription Drug Plan (PDP) Compensation
We also wanted to let you know some important information about Wellcare’s PDP products in 2025.
As you may know, the Inflation Reduction Act (IRA) has resulted in significant changes to Part D including:
- Elimination of the Coverage Gap or “donut hole”
- A new $2,000 out-of-pocket spending cap
- A shift in cost-sharing responsibility in the catastrophic coverage phase
- A new cost sharing smoothing option
To continue providing access to high-quality healthcare and Part D coverage that helps families and individuals, we have made a difficult decision – effective Jan. 1, 2025 – to cease new and renewal commissions for PDP beginning with the 2025 plan year.
This communication serves as notice of termination without cause of your existing TPME marketing services agreements with Centene for Medicare products effective Dec. 31, 2024. As noted above, Medicare Advantage product compensation will continue into 2025, with your new contract once executed.
If you have any questions, please contact your local sales leader.
We thank you for your continued partnership.